UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 370

Sortiert nach

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

The New England journal of medicine, 2017-03, Vol.376 (11), p.1027-1037

2017

Volltextzugriff (PDF)

Immunotherapy response assessment in neuro-oncology: a report of the RANO working group

The lancet oncology, 2015-11, Vol.16 (15), p.e534-e542

2015

Volltextzugriff (PDF)

MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients

Journal of clinical oncology, 2008-05, Vol.26 (13), p.2192-2197

2008

Volltextzugriff (PDF)

Implications of BRAF V600E mutation in gliomas: Molecular considerations, prognostic value and treatment evolution

Frontiers in oncology, 2023-01, Vol.12, p.1067252-1067252

2023

Volltextzugriff (PDF)

Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation With MGMT Promoter Methylation Status

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1275-1279

2009

Volltextzugriff (PDF)

Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas

CNS oncology, 2021-06, Vol.10 (2), p.CNS72

2021

Volltextzugriff (PDF)

Tumor-Associated Microenvironment of Adult Gliomas: A Review

Frontiers in oncology, 2022-07, Vol.12, p.891543-891543

2022

Volltextzugriff (PDF)

Glioblastoma Microenvironment: From an Inviolable Defense to a Therapeutic Chance

Frontiers in oncology, 2022-03, Vol.12, p.852950-852950

2022

Volltextzugriff (PDF)

DCVax-L Vaccination in Patients with Glioblastoma: Real Promise or Negative Trial? The Debate Is Open

Cancers, 2023-06, Vol.15 (12), p.3251

2023

Volltextzugriff (PDF)

Vorasidenib in IDH1/2-mutant low-grade glioma: the grey zone of patient's selection

Frontiers in oncology, 2024-01, Vol.13, p.1339266-1339266

2024

Volltextzugriff (PDF)

A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma

The oncologist (Dayton, Ohio), 2019-04, Vol.24 (4), p.521-528

2019

Volltextzugriff (PDF)

Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology

Neuro-oncology (Charlottesville, Va.), 2008-06, Vol.10 (3), p.361-367

2008

Volltextzugriff (PDF)

Editorial: Advances in brain tumors diagnosis and treatment

Frontiers in medicine, 2023-05, Vol.10, p.1152547-1152547

2023

Volltextzugriff (PDF)

Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?

Cancers, 2022-01, Vol.14 (2), p.333

2022

Volltextzugriff (PDF)

Glioblastoma: Emerging Treatments and Novel Trial Designs

Cancers, 2021-07, Vol.13 (15), p.3750

2021

Volltextzugriff (PDF)

CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gap

Frontiers in oncology, 2023-06, Vol.13, p.1206983-1206983

2023

Volltextzugriff (PDF)

Olfactory neuroblastoma: diagnosis, management, and current treatment options

Frontiers in oncology, 2023-10, Vol.13, p.1242453-1242453

2023

Volltextzugriff (PDF)

Tumor Microenvironment in Gliomas: A Treatment Hurdle or an Opportunity to Grab?

Cancers, 2023-02, Vol.15 (4), p.1042

2023

Volltextzugriff (PDF)

Adult Medulloblastoma: Updates on Current Management and Future Perspectives

Cancers, 2022-07, Vol.14 (15), p.3708

2022

Volltextzugriff (PDF)

Long‐term results of a prospective study on the treatment of medulloblastoma in adults

Cancer, 2007-11, Vol.110 (9), p.2035-2041

2007

Volltextzugriff (PDF)

Neuro-Oncology During the COVID-19 Outbreak: A Hopeful Perspective at the End of the Italian Crisis

Frontiers in medicine, 2020-11, Vol.7, p.594610-594610

2020

Volltextzugriff (PDF)

Defining EGFR amplification status for clinical trial inclusion

Neuro-oncology (Charlottesville, Va.), 2019-10, Vol.21 (10), p.1263-1272

2019

Volltextzugriff (PDF)

Connectome-Based Neurosurgery in Primary Intra-Axial Neoplasms: Beyond the Traditional Modular Conception of Brain Architecture for the Preservation of Major Neurological Domains and Higher-Order Cognitive Functions

Life (Basel, Switzerland), 2024-01, Vol.14 (1), p.136

2024

Volltextzugriff (PDF)

Relapsed Glioblastoma: Treatment Strategies for Initial and Subsequent Recurrences

Current treatment options in oncology, 2016-09, Vol.17 (9), Article 49

2016

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology: Hopes and Disappointments

Clinical cancer research, 2008-02, Vol.14 (4), p.957-960

2008

Volltextzugriff (PDF)

1 – 25 von 370

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(337)
Mit Volltextzugriff
(344)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neuro-Oncology
(31)
Journal Of Clinical Oncology
(27)
Expert Review Of Anticancer Therapy
(16)
Future Oncology
(15)
Frontiers In Oncology
(8)
Journal Of Neuro-Oncology
(8)
Journal Of The Less-Common Metals
(8)
Cancers
(7)
Cancer
(6)
European Journal Of Cancer
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

Immunotherapy response assessment in neuro-oncology: a report of the RANO working group

MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients

Implications of BRAF V600E mutation in gliomas: Molecular considerations, prognostic value and treatment evolution

Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation With MGMT Promoter Methylation Status

Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas

Tumor-Associated Microenvironment of Adult Gliomas: A Review

Glioblastoma Microenvironment: From an Inviolable Defense to a Therapeutic Chance

DCVax-L Vaccination in Patients with Glioblastoma: Real Promise or Negative Trial? The Debate Is Open

Vorasidenib in IDH1/2-mutant low-grade glioma: the grey zone of patient's selection

A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma

Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology

Editorial: Advances in brain tumors diagnosis and treatment

Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?

Glioblastoma: Emerging Treatments and Novel Trial Designs

CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gap

Olfactory neuroblastoma: diagnosis, management, and current treatment options

Tumor Microenvironment in Gliomas: A Treatment Hurdle or an Opportunity to Grab?

Adult Medulloblastoma: Updates on Current Management and Future Perspectives

Long‐term results of a prospective study on the treatment of medulloblastoma in adults

Neuro-Oncology During the COVID-19 Outbreak: A Hopeful Perspective at the End of the Italian Crisis

Defining EGFR amplification status for clinical trial inclusion

Connectome-Based Neurosurgery in Primary Intra-Axial Neoplasms: Beyond the Traditional Modular Conception of Brain Architecture for the Preservation of Major Neurological Domains and Higher-Order Cognitive Functions

Relapsed Glioblastoma: Treatment Strategies for Initial and Subsequent Recurrences

Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology: Hopes and Disappointments

Suchergebnisse filtern